Current News & Updates

New Propranolol Study

A newly published paper in the Journal of Clinical Investigation examines the impact of the medicine propranolol in zebrafish and mouse models of cerebral cavernous angioma. In explaining the relevance of the study, Dr. Issam Awad, the study’s co-PI states, “Propranolol, a widely used blood pressure and migraine medication, had long been known to be…

SAB Statement on COVID Vaccines

December 8, 2020 CONSENSUS STATEMENT BY THE ANGIOMA ALLIANCE SCIENTIFIC ADVISORY BOARD ABOUT COVID-19 VACCINE With anticipated approval by the U.S. Food and Drug Administration, long-awaited COVID-19 vaccines will soon be available. Based on exceptional effectiveness data (greater than 90% protection from COVID-19 illness), the durability of benefit after a recommended second dose, and minimal…